BioVie Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	19.46	18.64	4.51	0.04	0.34	0.05	0.01	0.12	0.27	0.33
Short-Term Investments	14.48	0	0	0	0	0	0	0	0	0
Cash & Cash Equivalents	33.94	18.64	4.51	0.04	0.34	0.05	0.01	0.12	0.27	0.33
Cash Growth	82.06%	313.19%	12029.70%	-89.06%	642.19%	791.05%	-95.85%	-53.73%	-19.64%	-
Other Current Assets	0.1	0.14	0.09	0.38	0.33	0	0	0.01	0	0
Total Current Assets	34.04	18.78	4.61	0.41	0.67	0.05	0.01	0.13	0.27	0.33
Property, Plant & Equipment	0.08	0.12	0	0	0	0	0	0	0	0
Goodwill and Intangibles	0.98	1.21	1.44	1.67	1.9	2.13	2.36	2.59	0	0
Other Long-Term Assets	0	0	0	0	0	0	0	0	0	0
Total Long-Term Assets	1.06	1.33	1.44	1.67	1.9	2.13	2.36	2.59	0	0
Total Assets	35.1	20.11	6.05	2.08	2.57	2.18	2.36	2.72	0.27	0.33
Accounts Payable	3.48	2.44	1	1.26	0.44	0.88	0.47	0.29	0	0
Current Debt	9.15	0.04	0	0.85	0	0	0.04	0.01	0	0
Other Current Liabilities	1.87	1.69	0	21.41	0	0.35	0.13	0.5	0.32	0.16
Total Current Liabilities	14.49	4.17	1	23.52	0.44	1.24	0.63	0.8	0.32	0.16
Long-Term Debt	5.27	12.23	0	0.06	0	0.83	0.58	0	0	0
Other Long-Term Liabilities	0	0.05	0	0	0	0	0	0	0	0
Total Long-Term Liabilities	5.27	12.27	0	0.06	0	0.83	0.58	0	0	0
Total Liabilities	19.76	16.44	1	23.58	0.44	2.06	1.21	0.8	0.32	0.16
Total Debt	14.42	12.26	0	0.91	0	0.83	0.61	0.01	0	0
Debt Growth	17.57%	-	-	-	-	35.19%	6009.18%	-	-	-
Retained Earnings	-301.23	-250.97	-224.89	-41.04	-7.26	-4.77	-2.34	-1	-0.57	-0.34
Comprehensive Income	0.18	0	0	0	0	0	0	0	0	0
Shareholders' Equity	15.34	3.67	5.05	-21.5	2.13	0.11	1.16	1.92	-0.05	0.17
Net Cash / Debt	19.52	6.38	4.51	-0.87	0.34	-0.78	-0.61	0.11	0.27	0.33
Net Cash / Debt Growth	206.09%	41.34%	-	-	-	-	-	-57.47%	-19.64%	-
Net Cash Per Share	0.60	0.26	0.36	-0.18	0.13	-1.02	-0.85	0.16	0.38	0.48
Working Capital	19.55	14.61	3.61	-23.11	0.23	-1.19	-0.63	-0.67	-0.05	0.17
Book Value Per Share	0.47	0.15	0.41	-4.36	0.84	0.14	1.62	2.75	-0.08	0.25

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).